Novel structurally similar chromene derivatives with opposing effects on p53 and apoptosis mechanisms in colorectal HCT116 cancer cells

European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
Cristovao F LimaCristina Pereira-Wilson

Abstract

In the present work, novel chromene derivatives fused with the imidazo[1,2-a]pyridine nucleus were tested for their anticancer potential in the human colorectal cancer HCT116 cells. Compounds 2a and 2c showed significant growth inhibitory activity with GI50 of 15 μM and 11 μM, respectively. Compound 2c, the most potent, has a carbamate group in position 8 of the pyridine ring, and showed significant cell cycle arrest and induction of cell death by apoptosis, even at 5 μM. Besides different potencies, chromene analogs 2a and 2c showed different mechanisms of action. Whereas the carbamate-free chromene 2a induced cell cycle arrest at G1/G0 phase, compound 2c showed to arrest cell cycle at both S and G2 phases. Chromene derivative 2a at concentrations higher than its GI50 remarkably induced caspases-dependent apoptosis in a p53-independent manner. On the other hand, compound 2c increased significantly p53 levels and induced apoptosis in a p53- and caspases-dependent manner, even at concentrations lower than its GI50. Both compounds increased the Bax/Bcl-2 ratio, induced mitochondria depolarization and activated MAP kinases. In conclusion, two novel and structurally similar chromene derivatives showed cytotoxicity to HCT16 cells th...Continue Reading

References

Sep 2, 1997·Proceedings of the National Academy of Sciences of the United States of America·J S LanniT Jacks
Jan 1, 2003·Seminars in Cancer Biology·Dan Michael, Moshe Oren
Feb 14, 2004·Cell Death and Differentiation·L BaiJ L Merchant
Jul 29, 2004·The Journal of Biological Chemistry·Mark K SavilleDavid P Lane
Sep 25, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·An Van LaethemPatrizia Agostinis
Feb 14, 2006·Current Medicinal Chemistry·Massimo CuriniGiovanni Giannone
Jul 22, 2006·Life Sciences·Cristovao F LimaCristina Pereira-Wilson
Feb 15, 2008·The Journal of Organic Chemistry·Marta CostaFernanda Proença
May 5, 2009·Cell·Karen H Vousden, Carol Prives
Jun 23, 2009·Cell Death and Differentiation·J T Lee, W Gu
Jul 16, 2010·European Journal of Medicinal Chemistry·Dong Hyuk NamYong Sup Lee
Jan 5, 2011·Bioorganic & Medicinal Chemistry Letters·Alexandra GasparFernanda Borges
Jan 13, 2011·The American Journal of Pathology·Bulbul Pandit, Andrei L Gartel
Apr 22, 2011·Organic & Biomolecular Chemistry·Marta CostaFernanda Proença
Aug 10, 2011·Current Medicinal Chemistry·I KostovaL Saso
Aug 11, 2011·Biochemical Pharmacology·Brahma N SinghRakesh K Srivastava
Apr 6, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Azmi YerlikayaEngin Ulukaya
Jul 27, 2012·Current Medicinal Chemistry·J-J QinR Zhang
Aug 11, 2012·Mini Reviews in Medicinal Chemistry·Guilherme Borges BubolsSolange Cristina Garcia
Aug 23, 2012·Journal of Biomedicine & Biotechnology·Razmik MirzayansDavid Murray
Nov 21, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Christian Frezza, Carla P Martins
Dec 19, 2012·Current Biology : CB·Benjamin L LampsonChristopher M Counter
Dec 25, 2012·Nature Cell Biology·Patricia A J Muller, Karen H Vousden
Jan 17, 2013·Cancer Treatment Reviews·Natalie TurnerAngelo Di Leo
Jun 19, 2013·European Journal of Medicinal Chemistry·Tatiana A DiasCristina Pereira-Wilson
Jul 5, 2013·Expert Opinion on Therapeutic Targets·Min ShenQ Ping Dou
Aug 8, 2013·World Journal of Gastroenterology : WJG·Aravind Suppiah, John Greenman
Sep 5, 2013·Therapeutic Advances in Gastroenterology·Sing Yu MoorcraftDavid Cunningham
Sep 13, 2013·Cancer Biology & Therapy·Paul Dent
Sep 13, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ashley Wong, Brigette B Y Ma
Oct 1, 2013·Critical Reviews in Oncology/hematology·Sally TemrazAli Shamseddine
Oct 17, 2013·The International Journal of Biochemistry & Cell Biology·Divyashree RavishankarHelen M I Osborn
Nov 7, 2014·Frontiers in Oncology·Johanna PflaumMartina Müller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.